Clinical Trial Update: Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, safety, and pharmacodynamics of HS235 in overweight/obese healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HS235

Snippet

Sponsor: 35Pharma Inc | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED